Trademark: 90620821
Word
MEDICAGO UNLEASH THE POWER OF PLANTS
Status
Registered
Status Code
700
Status Date
Tuesday, October 11, 2022
Serial Number
90620821
Registration Number
6868840
Registration Date
Tuesday, October 11, 2022
Mark Type
4000
Filing Date
Friday, April 2, 2021
Published for Opposition
Tuesday, July 26, 2022

Trademark Owner History
Medicago Inc. - Original Registrant

Classifications
40 Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
5 Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer
44 Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
42 Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates; Medical information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
as to "MEDICAGO"

Trademark Events
Oct 11, 2022
Notice Of Registration Confirmation Emailed
Oct 11, 2022
Registered-Principal Register
Jul 26, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 26, 2022
Published For Opposition
Jul 6, 2022
Notification Of Notice Of Publication E-Mailed
Jun 23, 2022
Approved For Pub - Principal Register
Jun 22, 2022
Examiner's Amendment Entered
Jun 22, 2022
Notification Of Examiners Amendment E-Mailed
Jun 22, 2022
Examiners Amendment E-Mailed
Jun 22, 2022
Examiners Amendment -Written
Jun 2, 2022
Teas/Email Correspondence Entered
Jun 2, 2022
Correspondence Received In Law Office
Jun 2, 2022
Assigned To Lie
May 25, 2022
Teas Response To Office Action Received
Nov 26, 2021
Notification Of Non-Final Action E-Mailed
Nov 26, 2021
Non-Final Action E-Mailed
Nov 26, 2021
Non-Final Action Written
Nov 17, 2021
Assigned To Examiner
Jul 11, 2021
New Application Office Supplied Data Entered In Tram
Apr 6, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24